Next Article in Journal
Differences in Resilience, Psychological Well-Being and Coping Strategies between HIV Patients and Diabetics
Next Article in Special Issue
Risk of Dehydration Due to Sweating While Wearing Personal 2 Protective Equipment in COVID-19 Clinical Care: A Pilot Study
Previous Article in Journal
Acknowledgment to Reviewers of Healthcare in 2021
Previous Article in Special Issue
Information Flow and Data Gaps in COVID-19 Recording and Reporting at National and Provincial Levels in Indonesia
Article

Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System

1
Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USA
2
Department of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32610, USA
*
Author to whom correspondence should be addressed.
Academic Editors: Giuseppe Di Martino, Tommaso Staniscia, Fabrizio Cedrone and Andrea Tittarelli
Healthcare 2022, 10(2), 264; https://doi.org/10.3390/healthcare10020264
Received: 19 December 2021 / Revised: 27 January 2022 / Accepted: 28 January 2022 / Published: 29 January 2022
(This article belongs to the Special Issue The Impact of COVID-19 on Healthcare Services)
During the first year of the coronavirus disease 2019 (COVID-19) pandemic, prevention measures included quarantining and facility closures. Because cancer screening is dependent on interventions in facilities, the extent of the COVID-19 impact on screening was questioned. A claims registry from a large health system was queried for colorectal and prostate cancer screening. A screening gap and screening loss ratio were calculated by comparing 2020 screening to historical reference years. All cancer screenings decreased in the first four months of the pandemic. Colorectal cancer screening returned to baseline in the latter six months of 2020. Prostate cancer screening exceeded baseline in the latter six months, but with a lesser gain than previous years. Populations disproportionately affected by decreased cancer screening included men and black people. To catch-up after the initial deficit in screening, it is estimated that the rate of colorectal cancer screening needs to increase by 50%. View Full-Text
Keywords: cancer screening; colorectal cancer; prostate cancer; COVID-19; health disparities; health policy; public health cancer screening; colorectal cancer; prostate cancer; COVID-19; health disparities; health policy; public health
Show Figures

Figure 1

MDPI and ACS Style

Kelkar, A.H.; Zhao, J.; Wang, S.; Cogle, C.R. Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System. Healthcare 2022, 10, 264. https://doi.org/10.3390/healthcare10020264

AMA Style

Kelkar AH, Zhao J, Wang S, Cogle CR. Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System. Healthcare. 2022; 10(2):264. https://doi.org/10.3390/healthcare10020264

Chicago/Turabian Style

Kelkar, Amar H., Jing Zhao, Shu Wang, and Christopher R. Cogle. 2022. "Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System" Healthcare 10, no. 2: 264. https://doi.org/10.3390/healthcare10020264

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop